HOME >> BIOLOGY >> NEWS
Field Museum awarded $5.2 million for community-based conservation in Peru

CHICAGO--The Field Museum has received $5.2 million from the U.S. Agency for International Development (USAID) to work with its partner, Centro de Conservacin, Investigacin y Manejo de Areas Naturales Cordillera Azul (CIMA) and other Peruvian and international organizations, to develop ecologically compatible opportunities for communities neighboring the huge new Parque Nacional Cordillera Azul in Peru.

"In addition to protecting a spectacular region with rich biological diversity, this park offers a unique opportunity for its neighboring communities in the Huallaga Valley," says Debra Moskovits, PhD, Director of The Field Museum's Environmental and Conservation Programs. "The park will generate long-term investments that engage local residents in activities that both support the park and improve their quality of life."

Creating income and job opportunities through the sustainable use of natural resources advances U.S. government objectives to create ecologically, politically and economically viable alternatives to the cultivation of illicit crops, according to Tim Miller, USAID/Peru's Chief of the Office of Environment and Natural Resources. "That's why our offices of environment and alternative development have joined forces to address common problems in Peru's coca-growing areas."

In April, USAID signed a cooperative agreement with the Museum for the program, Economic and Environmental Opportunities in Parque Nacional Cordillera Azul and its Buffer Zone, Huallaga (Coca) Valley, Peru, over the next four years. In the role of technical support for the implementation of the park, the Museum will work with CIMA to develop opportunities that are ecologically compatible with the park and culturally compatible with the local human communities.

The USAID grant will create jobs for local residents, reforest abandoned coca fields, and promote long-term stewardship of natural resources. These projects will be managed through conservatio
'"/>

Contact: Greg Borzo
gborzo@fieldmuseum.org
312-665-7106
Field Museum
13-Jun-2003


Page: 1 2 3

Related biology news :

1. Field Museum gives Parker/Gentry Award to Chinese conservationist
2. Field Museum maps social assets of Chicagos industrialized Lake Calumet region
3. Field Museum researcher co-edits definitive book on Madagascar
4. Field Museum gives prestigious Parker Gentry Award to Tanzanian anti-poaching activist
5. Field Museum uncovers evidence behind man-eating; revises legend of its infamous man-eating lions
6. Field Museum plays key role in massive project to map Tree of Life
7. Field Museums Parker/Gentry Award goes to Peruvian conservationists
8. Bhutan signs conservation agreement at Field Museum Jan. 22
9. Field trials used to investigate the social lives of badgers
10. Conservation biologist Michael Lannoo to win Field Museums Parker/Gentry Award
11. Field Museum plays vital role in creation of huge new park

Post Your Comments:
(Date:5/21/2013)... researchers have developed a new method for delivering ... in the cell surface. The technique could find ... biological fields. , Bulk electroporation a technique ... nanopores in the cell membrane that are caused ... an increasingly popular method of cell transfection. (Cell ...
(Date:5/21/2013)... keeping in shape is an uphill battle? Try staying ... prolonged weightlessness withers muscle and bone. , That,s the ... address with a new three-year, $1.2 million grant from ... exercise during multiyear exploratory missions. , "You could give ... you can,t get them to stick to it, it ...
(Date:5/21/2013)... 2013 Royal Philips Electronics (NYSE: PHG, AEX: ... portable ultrasound with Philips, industry leading Live 3D TEE, ... xMATRIX with available Live 3D TEE and ICE will ... the EuroPCR, official meeting for the European Association of ... its launch in 2012, Philips CX50 xMATRIX has been ...
Breaking Biology News(10 mins):Single-cell transfection tool enables added control for biological studies 2Fueling fitness on the final frontier 2Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2
(Date:5/22/2013)... 22, 2013  Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced ... Annual Marcum LLP Microcap Conference, May 30, in ... Neil Lyons , CPA, Chief Financial Officer of Cleveland ... May 30 at 1:30 p.m. Eastern Time.  A live and ... the Investors page of the Cleveland BioLabs website at ...
(Date:5/22/2013)... Express Diagnostics Int’l, Inc. (EDI) ... are pleased to announce a sponsorship agreement with Erebus ... Zealand distributor of DrugCheck® onsite testing devices, manufactured by ... the Austin 400 May 17-19 in Austin, Texas. , ... involves each car of the Erebus Motorsport team displaying ...
(Date:5/22/2013)... A recent study from researchers in Tasmania ... that those who took probiotics were able to run for ... showed that in extreme heat conditions, probiotics were able to ... acne treatment explains what this new discovery means for ... skin condition. , While researchers tote the benefits of ...
(Date:5/21/2013)... First patients dosed with PSX1002, ... designed using Prosonix, particle engineering platform Prosonix, ... inhaled Respiratory Medicines by Design , has initiated ... assess its effect on lung function and the safety ... to severe chronic obstructive pulmonary disease (COPD). The first ...
Breaking Biology Technology:Cleveland BioLabs to Present at Second Annual Marcum LLP Microcap Conference 2Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4
Cached News: